Invention Grant
- Patent Title: Compounds for treatment of cancer
-
Application No.: US16033953Application Date: 2018-07-12
-
Publication No.: US10525037B2Publication Date: 2020-01-07
- Inventor: Jin Wang , Jianjun Chen , Duane D. Miller , Wei Li
- Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
- Applicant Address: US TN Knoxville
- Assignee: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
- Current Assignee: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
- Current Assignee Address: US TN Knoxville
- Agency: Pearl Cohen Zedek Latzer Baratz LLP
- Agent Mark S. Cohen
- Main IPC: A61K31/4178
- IPC: A61K31/4178 ; A61K31/337 ; A61K31/437 ; A61K31/506 ; A61K31/519 ; A61K31/4174 ; A61K31/42 ; A61K31/335 ; A61K31/4164 ; A61K31/435
Abstract:
The present invention relates to pharmaceutical compositions for treating cancer comprising BRAF inhibitors, (e.g. vemurafenib) and/or MEK inhibitor, (e.g. trametinib, RO5068760), in combination with anti-tubulin compounds of the invention or other known tubulin inhibitors, and using such compositions for treating cancer such as melanoma, drug-resistant cancer, and cancer metastasis.
Public/Granted literature
- US20180325872A1 COMPOUNDS FOR TREATMENT OF CANCER Public/Granted day:2018-11-15
Information query
IPC分类:
